Brian Hartzband

- For the six months ended March 31, 2025, **total revenues decreased by 21.9%** to **$7,949,845** compared to the same period in 2024.  **[1816815_0001493152-25-015913_form6-k.htm:1]**  This decline was primarily driven by significant decreases in health supplemental powder drinks (**97.6% decrease**) and bioactive food ingredients (**68.9% decrease**), partially offset by a substantial **553.9% increase** in fragrance compound products.  **[1816815_0001493152-25-015913_form6-k.htm:2]** **[1816815_0001493152-25-015913_form6-k.htm:3]** 
- Despite lower revenues, Bon Natural Life Limited reported a **net income of $169,227** for the six months ended March 31, 2025, a significant improvement from a net loss of **$10,519** in the prior year.  **[1816815_0001493152-25-015913_form6-k.htm:1]** **[1816815_0001493152-25-015913_ex99-1.htm:1]**  **Income from operations increased by 236.1%** to **$284,050**.  **[1816815_0001493152-25-015913_form6-k.htm:1]** 
- Basic earnings per share (EPS) for the six months ended March 31, 2025, was **$0.56**, reversing a loss per share of **$0.20** from the comparable period in 2024.  **[1816815_0001493152-25-015913_form6-k.htm:1]** **[1816815_0001493152-25-015913_ex99-1.htm:1]** 
- This profitability turnaround was supported by effective cost control, with **total operating expenses decreasing by 43.7%**.  **[1816815_0001493152-25-015913_form6-k.htm:2]**  Notably, research and development expenses fell by **89.2%**, selling expenses by **33.7%**, and general and administrative expenses by **22.8%**.  **[1816815_0001493152-25-015913_form6-k.htm:2]** **[1816815_0001493152-25-015913_form6-k.htm:6]** 
- As of March 31, 2025, the company's cash position significantly improved to **$8,894,053** from **$80,466** at September 30, 2024, contributing to total assets of **$71,584,129** and total shareholders' equity of **$53,905,305**.  **[1816815_0001493152-25-015913_ex99-1.htm:0]**

Bon Natural Life (BON)